SCHEMBL6578565

SCHEMBL6578565

Cc1ccc(-n2c(=O)ccc3ccc(C#C[Si](C)(C)C)cc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 9/20 0.35
HTT P42858 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
NPC1 O15118 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
XBP1 P17861 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TLR9 Q9NR96 1/20 0.35
CYP2C9 P11712 1/20 0.34
APLNR P35414 1/20 0.34
KMT2A Q03164 2/20 0.33
CYP19A1 P11511 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRA5 P31644 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576502 0.81 TDP2 (0.36) TDP2HTTALDH1A1LMNANPC1
SCHEMBL15669157 0.71 HTT (0.39) HTTALDH1A1LMNANPC1MAPT
SCHEMBL3898768 0.71 HTR6 (0.44) HTTALDH1A1LMNAMAPTHPGD
SCHEMBL18674302 0.71 GABRA1 (0.36) ALDH1A1NPC1MAPTHPGDMAPK1
SCHEMBL8040091 0.70 CA12 (0.52) HTTALDH1A1LMNANPC1HSP90AA1
SCHEMBL440124 0.69 GRM5 (0.50) HTTALDH1A1LMNANPC1MAPT
SCHEMBL5015445 0.69 PTGS2 (0.42) HTTALDH1A1MAPTMAPK1RAB9A
SCHEMBL716385 0.67 GRM5 (0.54) HTTALDH1A1LMNANPC1MAPT
SCHEMBL1914269 0.67 CYP1A1 (0.38) GABRA1GABRA5GABRG2GABRB3GABRA3
SCHEMBL12986433 0.66 CYP1A2 (0.37) GABRA1GABRA5GABRG2GABRB3GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed